ArticleFrontiers in neurology2020

The Influence of Baseline Alzheimer's Disease Severity on Cognitive Decline and CSF Biomarkers in the NILVAD Trial.

Laila Abdullah et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.